catechin has been researched along with Angiogenesis, Pathologic in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (2.74) | 18.2507 |
2000's | 30 (41.10) | 29.6817 |
2010's | 37 (50.68) | 24.3611 |
2020's | 4 (5.48) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Cheung, CW; Chung, JPW; Fung, LWY; Hung, SW; Li, TC; Man, GCW; Wang, CC; Zhang, T | 1 |
Mei, B; Sun, Q; Xiao, Q; Zhang, T; Zhang, X | 1 |
Chen, CY; Lan, SJ; Lan, YH; Lin, YJ; Sheu, MJ; Wang, CCN | 1 |
Han, DS; Lee, EO; Lee, HJ; Yeo, C | 1 |
Gallemit, PEM; Malaitad, T; Thongboonkerd, V; Yoodee, S | 1 |
Brandl, MB; Cirillo, G; Kavallaris, M; Kimpton, K; Kumar, N; Pasquier, E; Vittorio, O; Yee, EMH | 1 |
Chen, J; Dong, W; Fu, B; Li, M; Qian, M; Zeng, Q; Zhang, Z | 1 |
Chen, J; Chen, K; Dai, W; Fan, X; Feng, J; Guo, C; Ji, J; Li, J; Li, S; Liu, T; Mao, Y; Wang, C; Wang, F; Wu, J; Wu, L; Yu, Q; Zhang, J; Zhou, Y | 1 |
Kroon, PA; Moyle, CWA; Needs, PW; Perez-Moral, N | 1 |
Chen, J; Chen, Z; Di, L; Hu, L; Huang, J; Li, J; Qiao, H; Wang, H; Wang, R; Yang, M | 1 |
Dupertuis, YM; Lecumberri, E; Miralbell, R; Pichard, C | 1 |
Feng, X; Feng, Y; Li, X; Liu, J; Tang, X; Zhou, K | 1 |
Fukusato, T; Kubota, S; Muraguchi, T; Sakamoto, Y; Terashita, N | 1 |
Hashimoto, O; Hiroshi, M; Inoue, K; Iwamoto, H; Nakamura, A; Nakamura, T; Sata, M; Torimura, T; Ueno, T | 1 |
Hrabec, E; Hrabec, Z; Lewandowska, U; Owczarek, K; Podsędek, A; Sosnowska, D; Szewczyk, K | 1 |
Fukunaga, K; Maruyama, T; Murata, S; Nakayama, K; Nowatari, T; Nozaki, R; Ogawa, K; Ohkohchi, N; Sano, N; Tamura, T | 1 |
Feng, LL; Liu, BX; Sun, LB; Yu, HS; Zhong, JY | 1 |
Chen, HY; Chiang, AN; Guo, BC; Lee, TS; Shyue, SK; Su, KH; Wei, J; Zhao, JF | 1 |
Lin, B; Liu, F; Liu, X; Shi, J; Tang, X; Zhang, W | 1 |
Bhatnagar, P; Gupta, KC; Kumar, P; Mishra, S; Shukla, Y; Singh, M | 1 |
Chen, YC; Gao, Y; Rankin, GO; Tu, Y | 1 |
Ahmed, RS; Chan, TH; Dou, QP; El-Banna, HA; El-Ghoneimy, AA; Farshi, P; Foldes, R; Liu, G; Renzetti, A; Saed, G; Soave, C; Yang, H | 1 |
Li, QS; Liang, YR; Lu, JL; Polito, CA; Wang, A; Xiang, LP; Ye, JH; Zheng, XQ | 1 |
Dhatwalia, SK; Dhawan, DK; Kumar, M | 1 |
Wang, H; Yang, CS | 1 |
Battaglini, M; Berger, L; Cirillo, G; Dente, L; di Leo, N; Giannaccini, M; Hampel, S; Raffa, V; Vittorio, O | 1 |
McGeary, A; Penack, O; Rudloff, S; Westphal, S; Wilke, A | 1 |
Goodarzi, M; Malekzadeh, M; Masoudifar, A; Mirzaei, H; Rashidi, B | 1 |
Chan, TH; Chan, WK; Lam, WH; Lee, SC; Lee, TW; Wang, X; Wong, YC | 1 |
Greene, GL; Leong, H; Mathur, PS | 1 |
Chu, CY; Lui, WT; Ng, PS; Rogers, MS; Wang, CC; Xu, H | 1 |
Cai, SR; He, YL; Wang, Z; Zhan, WH; Zhang, CH; Zhu, BH | 1 |
Hida, K; Hida, Y; Matsuda, K; Muraki, C; Ohga, N; Ohiro, Y; Shindoh, M; Totsuka, Y; Tsuchiya, K | 1 |
Baron, ED; Camouse, MM; Cooper, KD; Domingo, DS; Hsia, AH; Maes, D; Matsui, M; Ward, NL | 1 |
Asakawa, T; Kan, T; Oku, N; Piyaviriyakul, S; Shimizu, K; Siripong, P | 1 |
Shi, X; Xu, W; Yao, H; Zhang, Z | 1 |
Banik, NL; Karmakar, S; Mohan, N; Ray, SK | 1 |
Balacescu, L; Balacescu, O; Berindan-Neagoe, I; Braicu, C; Gherman, C; Irimie, F; Rus, M; Soritau, O; Tudoran, O; Virag, P | 1 |
Horikawa, K; Matsubara, K; Mizushina, Y; Nakajima, N; Saito, A; Tanaka, A; Yoshida, H | 1 |
Becker, CM; Birsner, AE; Chu, CY; D'Amato, RJ; Davis, TN; Kung, AL; Lui, WT; Wai Man, GC; Wang, CC; Xu, H | 1 |
Wu, H; Xiao, Y; Xin, Y; Zhao, J | 1 |
Banik, NL; Hossain, MM; Ray, SK | 1 |
Chan, TH; Cheng, JT; Chu, CY; Chu, KO; He, YX; Kwong, J; Lau, TS; Li, G; Man, GC; Qin, L; Wang, CC; Xu, H; Zhang, T | 1 |
Marsh, L; Shankar, S; Srivastava, RK | 1 |
Barañao, RI; Bastón, JI; Bilotas, MA; Meresman, GF; Olivares, CN; Ricci, AG; Singla, JJ | 1 |
He, L; Le, AD; Li, X; Shi, J; Tang, X; Zhang, E; Zhang, Q; Zhou, K | 1 |
Beatty, P; Brooks, MN; Elashoff, D; Elashoff, R; Go, VL; Heber, D; Sartippour, MR; Zhang, L | 1 |
Albini, A; Benelli, R; Calabrese, F; Dell'Aica, I; Donà, M; Garbisa, S; Morini, M | 1 |
Meydani, M; Nguyen, N; Tang, FY | 1 |
Hitsuda, Y; Igishi, T; Kodani, M; Matsumoto, S; Nakanishi, H; Shigeoka, Y; Shimizu, E; Yasuda, K | 1 |
Gouni-Berthold, I; Sachinidis, A | 1 |
Akizawa, T; Asai, T; Matsukawa, M; Oku, N; Uchida, T; Yamakawa, S | 1 |
Albini, A; Benelli, R; Fassina, G; Minghelli, S; Morini, M; Noonan, DM; Venè, R | 1 |
Chao, WT; Chen, YT; Lai, HC; Yang, VC | 1 |
Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
Dulak, J | 1 |
Band, MA; Guo, W; Liu, L; Meydani, M; Paulson, EK; Rodriguez, SK | 1 |
Adhami, VM; Mukhtar, H; Saleem, M; Siddiqui, IA | 1 |
Afaq, F; Ahmad, N; Khan, N; Mukhtar, H; Saleem, M | 1 |
Bayer, DK; Beltz, LA; Moss, AL; Simet, IM | 1 |
Chiang, EP; Shih, CJ; Tang, FY | 1 |
Blumberg, JB; Boucher, Y; Eisenberg, DM; Held, KD; Jain, RK; Kashiwagi, S; Lawenda, BD; Loeffler, JS; Niemierko, A; Silverstein, JR; Smith, DE; Xu, L | 1 |
Biggin, S; Caniato, R; Dell'Aica, I; Garbisa, S | 1 |
Cai, SR; He, YL; Li, ZR; Ma, JP; Peng, JS; Wang, Z; Zhan, WH; Zhang, CH; Zhu, BH | 1 |
Ganapathy, S; Shankar, S; Srivastava, RK | 1 |
Buxton, IL; Javed, MA; Law, WE; Rumjahn, SM; Wong, N | 1 |
Ganapathy, S; Hingorani, SR; Shankar, S; Srivastava, RK | 1 |
Adhami, VM; Asim, M; Hafeez, BB; Malik, A; Mukhtar, H; Sarfaraz, S; Siddiqui, IA | 1 |
Hsiao, TY; Kok, SH; Lin, SK; Liu, CM; Shun, CT; Wang, CC | 1 |
Cao, R; Cao, Y | 1 |
L'Allemain, G | 1 |
Albini, A; De Flora, S; Ferrari, N; Tosetti, F | 1 |
Ellis, LM; Jung, YD | 1 |
16 review(s) available for catechin and Angiogenesis, Pathologic
Article | Year |
---|---|
Therapeutic effects of green tea on endometriosis.
Topics: Apoptosis; Catechin; Endometriosis; Female; Humans; Neovascularization, Pathologic; Tea | 2023 |
Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Cycle; Chemotherapy, Adjuvant; Humans; Neoplasms; Neovascularization, Pathologic; Polyphenols; Tea | 2013 |
Suppressive Effects of Tea Catechins on Breast Cancer.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Antioxidants; Breast Neoplasms; Camellia sinensis; Catechin; Dietary Supplements; Evidence-Based Medicine; Female; Food Handling; Functional Food; Gallic Acid; Humans; Intestinal Absorption; Neovascularization, Pathologic; Oxidation-Reduction; Plant Extracts; Plant Leaves; Reproducibility of Results; Risk; Tea | 2016 |
Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Artemisinins; Catechin; Cell Proliferation; Curcumin; Humans; Neoplasms; Neovascularization, Pathologic; Plant Extracts; Resveratrol; Stilbenes; Triterpenes | 2016 |
Cancer Preventive Activities of Tea Catechins.
Topics: Animals; Apoptosis; Catechin; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Neoplasms; Neovascularization, Pathologic; Tea | 2016 |
Green tea and its anti-angiogenesis effects.
Topics: Animals; Catechin; Humans; MicroRNAs; Neovascularization, Pathologic; Tea; Vascular Endothelial Growth Factors | 2017 |
Dietary flavonoids as cancer prevention agents.
Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Curcumin; Diet; Flavonoids; Food; Humans; Isothiocyanates; Neovascularization, Pathologic; Signal Transduction | 2011 |
Molecular mechanisms explaining the preventive effects of catechins on the development of proliferative diseases.
Topics: Animals; Apoptosis; Camellia sinensis; Catechin; Coronary Artery Disease; Growth Substances; Humans; Neoplasms; Neovascularization, Pathologic; Reactive Oxygen Species; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tea | 2004 |
Nutraceuticals as anti-angiogenic agents: hopes and reality.
Topics: Angiogenesis Inhibitors; Animals; Atherosclerosis; Catechin; Curcumin; Dietary Supplements; Flavonoids; Humans; Neoplasms; Neovascularization, Pathologic; Phenols; Polyphenols; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A | 2005 |
Beneficial effects of tea and its polyphenols against prostate cancer.
Topics: Androgens; Animals; Apoptosis; Catechin; Cell Cycle; Clinical Trials as Topic; Fermentation; Flavonoids; Gene Expression; Humans; Male; Neoplasm Transplantation; Neovascularization, Pathologic; Phenols; Polyamines; Polyphenols; Prostate-Specific Antigen; Prostatic Neoplasms; Signal Transduction; Tea | 2006 |
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Clinical Trials as Topic; ErbB Receptors; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; NF-kappa B; Protease Inhibitors; Receptor, IGF Type 1; Signal Transduction; Tea; Vascular Endothelial Growth Factor A | 2006 |
Mechanisms of cancer prevention by green and black tea polyphenols.
Topics: Animals; Antioxidants; Apoptosis; Arachidonic Acid; Catechin; Cell Cycle; Cell Proliferation; fas Receptor; Flavonoids; Gene Expression; Humans; Lipid Peroxidation; Lipoproteins, LDL; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; NF-kappa B; Nitric Oxide; Oncogenes; Oxidation-Reduction; Phenols; Polyphenols; Proteasome Inhibitors; Reactive Oxygen Species; Receptors, Androgen; Receptors, Aryl Hydrocarbon; Receptors, Growth Factor; Tea; Telomere; Tetrahydrofolate Dehydrogenase | 2006 |
Matrix proteases, green tea, and St. John's wort: biomedical research catches up with folk medicine.
Topics: Animals; Anti-Inflammatory Agents; Bridged Bicyclo Compounds; Catechin; Humans; Hypericum; Matrix Metalloproteinases; Neovascularization, Pathologic; Phloroglucinol; Pulmonary Fibrosis; Tea; Terpenes | 2007 |
Green tea polyphenols: biology and therapeutic implications in cancer.
Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Cell Proliferation; Flavonoids; Gene Expression Regulation; Humans; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Phenols; Polyphenols; Signal Transduction; Tea | 2007 |
Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents.
Topics: Acetylcysteine; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Catechin; Flavonoids; Humans; Models, Biological; Neoplasms; Neovascularization, Pathologic; Protease Inhibitors; Receptors, Cytoplasmic and Nuclear | 2002 |
Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Catechin; Humans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Phytotherapy; Plant Extracts; Tea | 2001 |
1 trial(s) available for catechin and Angiogenesis, Pathologic
Article | Year |
---|---|
Anti-angiogenic effects of epigallocatechin-3-gallate in human skin.
Topics: Administration, Cutaneous; Adult; Angiogenesis Inhibitors; Catechin; Dosage Forms; Double-Blind Method; Erythema; Face; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Male; Middle Aged; Neovascularization, Pathologic; Skin; Telangiectasis; Vascular Endothelial Growth Factor A | 2010 |
56 other study(ies) available for catechin and Angiogenesis, Pathologic
Article | Year |
---|---|
Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway.
Topics: Biflavonoids; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Mouth Neoplasms; Neovascularization, Pathologic; Proanthocyanidins; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2022 |
Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells.
Topics: Angiogenesis Inhibitors; Catechin; Cell Movement; Cell Proliferation; Cells, Cultured; Endoglin; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Neoplasm Invasiveness; Neovascularization, Pathologic; Pyrroles; Signal Transduction; Smad1 Protein; Vascular Endothelial Growth Factor A | 2019 |
Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.
Topics: Antigens, CD; Cadherins; Catechin; Cell Line, Tumor; Cell Survival; Down-Regulation; Humans; Male; Neoplasm Invasiveness; Neovascularization, Pathologic; Nuclear Proteins; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Twist-Related Protein 1 | 2020 |
Epigallocatechin-3-gallate plays more predominant roles than caffeine for inducing actin-crosslinking, ubiquitin/proteasome activity and glycolysis, and suppressing angiogenesis features of human endothelial cells.
Topics: Angiogenesis Inhibitors; Caffeine; Catechin; Cell Line, Tumor; Cell Proliferation; Coffee; Cross-Linking Reagents; Endothelial Cells; Endothelium, Vascular; Glycolysis; Humans; Matrix Metalloproteinase 2; Neovascularization, Pathologic; Proteasome Endopeptidase Complex; Tea; Ubiquitin; Ubiquitination | 2021 |
Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells.
Topics: Animals; Antineoplastic Agents; Catechin; Cation Transport Proteins; Cell Survival; Cells, Cultured; Copper; Copper Transport Proteins; Copper Transporter 1; Dextrans; Disease Models, Animal; Endothelial Cells; Heterografts; Homeostasis; Humans; Metallochaperones; Molecular Chaperones; Neoplasm Transplantation; Neovascularization, Pathologic; Neuroblastoma; Reactive Oxygen Species; Trace Elements; Treatment Outcome | 2017 |
Epicatechin Gallate Protects HBMVECs from Ischemia/Reperfusion Injury through Ameliorating Apoptosis and Autophagy and Promoting Neovascularization.
Topics: Antioxidants; Apoptosis; Autophagy; Catechin; Humans; Neovascularization, Pathologic; Reperfusion Injury; Stroke; Tea | 2019 |
Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis.
Topics: Animals; Biflavonoids; Carbon Tetrachloride; Catechin; Cell Line; Cell Proliferation; Down-Regulation; Hedgehog Proteins; Hepatic Stellate Cells; Humans; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Morphogenesis; Neovascularization, Pathologic; Proanthocyanidins; Signal Transduction; Transforming Growth Factor beta1; Veratrum Alkaloids | 2019 |
Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors.
Topics: Catechin; Cell Proliferation; Circular Dichroism; Flavonoids; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Neovascularization, Pathologic; Polyphenols; Protein Binding; Protein Structure, Secondary; Signal Transduction; Surface Plasmon Resonance; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles.
Topics: Animals; Apoptosis; Catechin; Colonic Neoplasms; Fluorouracil; HT29 Cells; Humans; Mice; Nanoconjugates; Neovascularization, Pathologic; Wheat Germ Agglutinins; Xenograft Model Antitumor Assays | 2019 |
Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression.
Topics: Base Sequence; Catechin; Cell Line, Tumor; DNA Primers; Down-Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin-Like Growth Factor I; Lung Neoplasms; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2013 |
Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis.
Topics: Animals; Antineoplastic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endostatins; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; RNA, Messenger; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2013 |
Methylated-(3'')-epigallocatechin gallate analog suppresses tumor growth in Huh7 hepatoma cells via inhibition of angiogenesis.
Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Mice; Mitogen-Activated Protein Kinase 1; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |
Procyanidins from evening primrose (Oenothera paradoxa) defatted seeds inhibit invasiveness of breast cancer cells and modulate the expression of selected genes involved in angiogenesis, metastasis, and apoptosis.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Biflavonoids; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoprevention; Female; Humans; Ki-67 Antigen; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neovascularization, Pathologic; Oenothera; Plant Extracts; Proanthocyanidins; Proto-Oncogene Proteins c-fos; RNA, Messenger; Seeds; Vascular Endothelial Growth Factor A | 2013 |
(-)-Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Enzyme Activation; HCT116 Cells; Humans; Liver Neoplasms; Male; Mice; Mice, SCID; Neovascularization, Pathologic; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
Effect of grape procyanidins on tumor angiogenesis in liver cancer xenograft models.
Topics: Animals; Antioxidants; Biflavonoids; Carcinoma, Hepatocellular; Catechin; Humans; Immunoenzyme Techniques; Liver Neoplasms; Mice; Neovascularization, Pathologic; Phytotherapy; Proanthocyanidins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vitis; Xenograft Model Antitumor Assays | 2014 |
Transient receptor potential vanilloid type 1 is vital for (-)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase.
Topics: AMP-Activated Protein Kinases; Anilides; Animals; Calcium; Capsaicin; Catechin; Cell Movement; Cell Proliferation; Cell Survival; Cinnamates; Endothelial Cells; HEK293 Cells; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Signal Transduction; Tea; TRPV Cation Channels | 2015 |
Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Nicotine; Smoking; Tea; Xenograft Model Antitumor Assays | 2015 |
PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Biflavonoids; Carcinoma, Ehrlich Tumor; Catechin; Cell Count; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Female; Flow Cytometry; Humans; Kinetics; Lactic Acid; Mice; Mitochondria; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyphenols; Reactive Oxygen Species; Tea | 2015 |
Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.
Topics: Biflavonoids; Carcinoma; Catechin; Cell Line, Tumor; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitogen-Activated Protein Kinase Kinases; Neovascularization, Pathologic; Oncogene Protein v-akt; Ovarian Neoplasms; Proto-Oncogene Proteins c-myc; Receptor, Notch1; Signal Transduction; Vascular Endothelial Growth Factor A | 2016 |
Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.
Topics: Apoptosis; Blotting, Western; Catechin; Cell Movement; Cell Proliferation; Female; Fluorescent Antibody Technique; Humans; Leiomyoma; Neovascularization, Pathologic; Prodrugs; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tea; Tumor Cells, Cultured; Uterine Neoplasms | 2016 |
A catechin nanoformulation inhibits WM266 melanoma cell proliferation, migration and associated neo-angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Compounding; Humans; Melanoma; Nanoparticles; Neovascularization, Pathologic; Xenograft Model Antitumor Assays; Zebrafish | 2017 |
The Green Tea Catechin Epigallocatechin Gallate Ameliorates Graft-versus-Host Disease.
Topics: Alkaloids; Allografts; Animals; Antioxidants; Benzodioxoles; Catechin; Disease Models, Animal; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neovascularization, Pathologic; Oxidative Stress; Piperidines; Polyunsaturated Alkamides; Quercetin; T-Lymphocytes, Regulatory; Tea | 2017 |
Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Topics: Acetates; Androgens; Animals; Apoptosis; Biological Availability; Catechin; Cell Division; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Prodrugs; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Tea; Transplantation, Heterologous | 2008 |
Green tea catechins inhibit angiogenesis through suppression of STAT3 activation.
Topics: Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Movement; Endothelial Cells; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Gene Expression Regulation; Humans; Immunohistochemistry; Immunoprecipitation; Interferon-gamma; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; Tea; Transfection; Vascular Endothelial Growth Factor A | 2009 |
Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model.
Topics: Angiogenesis Inhibitors; Animals; Catechin; Cell Proliferation; Disease Models, Animal; Endometriosis; Endometrium; Female; Humans; Mice; Mice, SCID; Microcirculation; Neovascularization, Pathologic; Tea; Vitamin E | 2009 |
[Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
Topics: Animals; Catechin; Cell Line, Tumor; Female; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2009 |
Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
Topics: Animals; Anticarcinogenic Agents; Blotting, Western; Catechin; Cell Line, Tumor; Cell Movement; Down-Regulation; Endothelial Cells; Flavonoids; Flow Cytometry; Gene Expression; Humans; Matrix Metalloproteinase 9; Melanoma; Mice; Microvessels; Neovascularization, Pathologic; Phenols; Polyphenols; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stem Cells; Tea; Xenograft Model Antitumor Assays | 2009 |
Anti-angiogenic activity and intracellular distribution of epigallocatechin-3-gallate analogs.
Topics: Actins; Angiogenesis Inhibitors; Biological Transport; Camellia sinensis; Catechin; Cell Line; Cell Movement; Cell Proliferation; Cytoplasm; Endothelial Cells; Endothelium, Vascular; Humans; Mitochondria; Neovascularization, Pathologic; Plant Extracts | 2011 |
SU5416 and EGCG work synergistically and inhibit angiogenic and survival factors and induce cell cycle arrest to promote apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-BE2 cells.
Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; E2F1 Transcription Factor; Humans; In Situ Nick-End Labeling; Indoles; Neovascularization, Pathologic; Neuroblastoma; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Retinoblastoma Protein; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells.
Topics: Angiogenesis Inhibitors; Apoptosis; Catechin; Cell Adhesion; Cell Movement; Cell Proliferation; Collagen; Drug Combinations; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Laminin; Neoplasm Invasiveness; Neovascularization, Pathologic; Proteoglycans; Signal Transduction; Transcription, Genetic; Uterine Cervical Neoplasms | 2012 |
Acylated catechin derivatives: inhibitors of DNA polymerase and angiogenesis.
Topics: Acylation; Animals; Catechin; Enzyme Inhibitors; Neovascularization, Pathologic; Nucleic Acid Synthesis Inhibitors; Rats; Rats, Wistar | 2011 |
Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
Topics: Adult; Animals; Catechin; Cells, Cultured; Endometriosis; Female; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Random Allocation; Signal Transduction; Tea; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells.
Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Caspases; Catechin; Cell Differentiation; Cell Line, Tumor; Cell Movement; Gene Knockdown Techniques; Humans; Inhibitor of Apoptosis Proteins; Neovascularization, Pathologic; Neuroblastoma; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Survivin | 2012 |
Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biological Availability; Catechin; Endometriosis; Endometrium; Female; Mice; Neovascularization, Pathologic; Ovarian Follicle; Oxidation-Reduction; Prodrugs; Tea | 2013 |
EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Catechin; Cell Line, Tumor; Cell Proliferation; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Neuropilins; Pancreas; Pancreatic Neoplasms; Proliferating Cell Nuclear Antigen; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Natural therapies assessment for the treatment of endometriosis.
Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Apoptosis; Catechin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Female; Humans; Injections, Intraperitoneal; Intestinal Diseases; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Random Allocation; Resveratrol; Stilbenes | 2013 |
(-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
Topics: Angiogenesis Inhibitors; Animals; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Gene Expression; Human papillomavirus 16; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-8; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Oncogene Proteins; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Repressor Proteins; Signal Transduction; Transfection; Vascular Endothelial Growth Factor A | 2013 |
Inhibition of fibroblast growth factors by green tea.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Breast Neoplasms; Catechin; Cells, Cultured; Endothelium, Vascular; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Humans; Neovascularization, Pathologic; Plant Extracts; RNA, Messenger; Tea | 2002 |
Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Catechin; Collagen; Drug Combinations; Fluorescein-5-isothiocyanate; Humans; Injections, Subcutaneous; Laminin; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Neovascularization, Pathologic; Neutrophil Activation; Neutrophil Infiltration; Neutrophils; Oxidants; Plant Extracts; Proteoglycans; Pulmonary Fibrosis; Tea | 2003 |
Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule.
Topics: Angiogenesis Inhibitors; Antigens, CD; Antineoplastic Agents; Blotting, Western; Cadherins; Catechin; Cell Division; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; In Vitro Techniques; Lasers; Neovascularization, Pathologic; Phosphorylation; Precipitin Tests; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Tea; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2003 |
Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-beta through Akt inhibition.
Topics: Adenocarcinoma; Antineoplastic Agents; Caffeic Acids; Catechin; Cell Movement; Curcumin; Humans; Lung Neoplasms; Neovascularization, Pathologic; NF-kappa B; Phenylethyl Alcohol; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Sulindac; Transforming Growth Factor beta; Tumor Cells, Cultured | 2004 |
(-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Catechin; Cell Division; Cell Movement; Colonic Neoplasms; Endothelium, Vascular; Humans; Matrix Metalloproteinase 14; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Methylcholanthrene; Mice; Neovascularization, Pathologic; Sarcoma, Experimental; Tumor Cells, Cultured; Umbilical Veins; Urokinase-Type Plasminogen Activator | 2004 |
Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
Topics: Animals; Apoptosis; Capillaries; Catechin; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Nude; Neovascularization, Pathologic; NIH 3T3 Cells; Plant Preparations; Sarcoma, Kaposi; Tea; Vascular Neoplasms; Xenograft Model Antitumor Assays | 2004 |
Effect of EGCG, a major component of green tea, on the expression of Ets-1, c-Fos, and c-Jun during angiogenesis in vitro.
Topics: Animals; Anticarcinogenic Agents; Aorta; Blotting, Western; Catechin; Cell Culture Techniques; Cell Division; Collagen; Culture Media; Down-Regulation; Endothelial Cells; Morphogenesis; Neovascularization, Pathologic; Proto-Oncogene Protein c-ets-1; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ets; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Transcription Factors; Umbilical Veins | 2004 |
Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Topics: Arginine; Ascorbic Acid; Bone Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Lysine; Matrix Metalloproteinases; Neovascularization, Pathologic; Nutritional Physiological Phenomena; Osteosarcoma; Proline; Sarcoma, Ewing; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
Topics: Catechin; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Neoplasms; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Signal Transduction; Tea; Umbilical Veins; Vascular Endothelial Growth Factor A | 2006 |
Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells.
Topics: Catechin; Cell Movement; Endothelium, Vascular; Ephrin-A1; Ephrin-A2; Humans; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Recombinant Proteins; Tea; Umbilical Veins | 2007 |
Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma.
Topics: Animals; Apoptosis; Breast Neoplasms; Carcinoma; Catechin; Cell Proliferation; Cells, Cultured; Combined Modality Therapy; Dietary Supplements; Female; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Pilot Projects; Radiation-Protective Agents; Vitamin E | 2007 |
(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
Topics: Animals; Anticarcinogenic Agents; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endothelial Cells; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; STAT3 Transcription Factor; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |
Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase.
Topics: Adenosine Triphosphate; Breast Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Ellagic Acid; Endothelial Cells; Humans; Neovascularization, Pathologic; Nucleoside-Diphosphate Kinase; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Tumor Cells, Cultured | 2007 |
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
Topics: Animals; Catechin; Cell Proliferation; Endothelium, Vascular; Extracellular Signal-Regulated MAP Kinases; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreatic Neoplasms | 2008 |
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Camellia sinensis; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Humans; Male; Neovascularization, Pathologic; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2008 |
Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis.
Topics: Antioxidants; Camellia sinensis; Catechin; Cell Hypoxia; Cells, Cultured; Cobalt; Fibroblasts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Nasal Polyps; Neovascularization, Pathologic; Plant Extracts; Vascular Endothelial Growth Factor A | 2008 |
Angiogenesis inhibited by drinking tea.
Topics: Animals; Catechin; Cattle; Corneal Neovascularization; Drinking; Endothelium, Vascular; Mice; Neovascularization, Pathologic; Rats; Tea; Tumor Cells, Cultured | 1999 |
[Multiple actions of EGCG, the main component of green tea].
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Division; Humans; Neovascularization, Pathologic; Tea | 1999 |